Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis.
Mathais S, Moisset X, Pereira B, Taithe F, Ciron J, Labauge P, Dulau C, Laplaud D, De Seze J, Pelletier J, Berger E, Lebrun-Frenay C, Castelnovo G, Edan G, Defer G, Vermersch P, Bourre B, Camdessanche JP, Magy L, Guennoc AM, Mathey G, Moreau T, Gout O, Heinzlef O, Maillart E, Vukusic S, Clavelou P; SFSEP and OFSEP investigators.
Mathais S, et al.
Neurotherapeutics. 2021 Jan;18(1):378-386. doi: 10.1007/s13311-020-00926-2. Epub 2020 Sep 22.
Neurotherapeutics. 2021.
PMID: 32964402
Free PMC article.
We conducted a French, multicenter, retrospective study, comparing a group of PMS patients treated with HDB to a matched control group. Poisson regression was applied to model the specific statistical distribution of the annualized relapse rate (ARR). ...
We conducted a French, multicenter, retrospective study, comparing a group of PMS patients treated with HDB to a matched control group. P …